Keyword: Acorda Therapeutics
News
25.09.2014
- US-based Acorda Therapeutics has acquired privately held Civitas Therapeutics for $525 million to gain access to a Parkinson's disease drug in late-stage development. With the buy...
News
22.12.2011
- GlaxoSmithKline executive German Pasteris is in charge of an Alzheimer's treatment that is years from reaching the market, if it ever does. But he already wants to make sure the...
